98 evolution "https:" "https:" "https:" "UNIVERSITY OF MACAU" PhD positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
ATMPs via the European Medicines Agency: https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview If you are curious, internationally minded, and driven by a
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
. The position is embedded in a broader research agenda on trustworthy, data-driven software engineering and AI-assisted development. The successful candidate will work on Bug Report Intelligence
-
: 04/07/2026 Prae Doc https://vds-physics.univie.ac.at/open-calls/completion-funding/#c1097213
-
technical support. You can find more information about the group and the institute at https://www.tuwien.at/en/etit/isas/mst . TU Wien is committed to increasing the proportion of women in particular in
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
is accessible online: https://www.tec21.fr/phd-tec21 What we offer : 7 fully funded PhD positions with employment contract, competitive salary (monthly estimate net salary between 2 050 and 2 150 EUR
-
DTU Tenure Track Researcher on Nanoreactors for Operando Visualizations of Nanoparticle Catalysis...
microscopy for nanoparticle catalysis at the Center for Visualizing Catalytic Processes (VISION). Responsibilities and qualifications You will engage with VISION’s development and application of nanoreactors
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient